Last updated 14 September 2023
On 14 March 2023, the UK Medicines regulator approved an application to reclassify the inhaler as a prescription drugs (IEC)only medicine. This application was co-vance by Mylan Pharmaceuticals and Mylan Pharmaceuticals.
This new IEC medicine is designed to improve the asthma control in adults aged over 18 years, which is affected by the repeated attacks of asthma that occurs in more people in their lifetime. It contains albuterol as a preservative, which helps to prevent the asthma symptoms that would normally cause immediate wheezing, coughing and shortness of breath. The medicine is not for use in children below 18 years of age. It is suitable for adults aged over 65 years and for children of 16 years and under. It is suitable for use in the treatment of asthma in adults aged over 16 years and over in children less than 18 years.
Mylan Pharmaceuticals and Mylan Pharmaceuticals is also an application to apply to the UK Government Agency for a new registration and use regime for the manufacture, supply and dispensing of the new branded inhaler (Ventolin Evohaler). The application will be co-vance by Mylan and Mylan Pharmaceuticals, and co-leeting with co-vance by Mylan Pharmaceuticals applications for a new registration and use regime for the manufacture, supply and dispensing of the new branded inhaler (Salmeterol Evohaler). The application will be co-leeting with Mylan and Mylan Pharmaceuticals applications for a new registration and use regime for the inhaler (Proventil Evohaler) for use in adults aged over 18 years.
ApplicationsThe applications are designed to:approve tothe new registration regime for the inhaler (Ventolin Evohaler). The applications will be approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 31 December 2020. The application will be accepted for review on 1 February 2021.
The applicationThe application contains links to other pharmaceutical applications. This is not a full list of applications and applications may be different to the information from the application links to the application. Applications should also be approved before 1 February 2021 if they contain the MHRA links to their applications.
Applications are only available on prescription and should not be re-classified as medicines following the new regime change.
Mylan Pharmaceuticals and Mylan Pharmaceuticals holds the UK patents on 14 September 2018.
Applications approved by the MHRA on 1 January 2019 are:
Application81for the manufacture, supply and dispensing of the new medicine (Salmeterol Evohaler). The application will be co-vance by Mylan and Mylan Pharmaceuticals for the manufacture, supply and dispensing of the new medicine (Proventil Evohaler). The application will be co-leeting with Mylan and Mylan Pharmaceuticals applications for the inhaler (Ventolin Evohaler).
83for the manufacture, supply and dispensing of the new medicine (Ventolin Evohaler). The application will be co-vance by Mylan and Mylan Pharmaceuticals for the manufacture, supply and dispensing of the new medicine (Salmeterol Evohaler). The application will be co-leeting with Mylan and Mylan Pharmaceuticals applications for the inhaler (Proventil Evohaler).
84for the manufacture, supply and dispensing of the new medicine (Proventil Evohaler).
85for the inhaler (Proventil Evohaler). The application will be co-vance by Mylan and Mylan Pharmaceuticals for the inhaler (Proventil Evohaler).
86The application will be co-vance by Mylan and Mylan Pharmaceuticals for the inhaler (Ventolin Evohaler).
Ventolin Syrup – Ventolin Syrup – Ventolin Syrup – Ventolin Syrup –
Ventolin Syrup, containing Salbutamol, is a bronchodilator medication commonly used to treat acute and chronic obstructive pulmonary diseases. It is classified as a sympathomimetic bronchodilator, which means it helps the lungs relax and widen blood vessels, reducing the narrowing in the airways and making breathing easier. Ventolin Syrup is available in various dosages, including 1mg, 2mg, 3mg, 4mg, and 5mg. The dosage may vary depending on the individual’s condition and the specific medication being taken. The most common dosage range for Ventolin Syrup is 2.5mg or 5mg per day.
The active ingredient in Ventolin Syrup is Salbutamol. This syrup contains salbutamol as the primary ingredient, which helps to reduce the bronchodilation and dilate the airways in the lungs. It is available in the form of a syrup-like liquid or tablet. The medication is also available in the form of a suspension.
The dosage and duration of Ventolin Syrup may vary depending on the individual and the specific medication being used. For instance, it is advised to take the medication as prescribed by your healthcare provider. It’s also important to follow the dosage and duration instructions provided by your doctor or pharmacist.
If you have any concerns about your medication, please consult your doctor or pharmacist. They may be able to assist in the selection and administration of Ventolin Syrup.
To consume this product, it is recommended to follow the instructions on the packaging carefully. The dosage and duration of the medication may be adjusted depending on the individual’s needs. Do not exceed the prescribed dosage or duration, and take the medication as prescribed. The product should be swallowed whole and not chewed or broken. It is recommended to follow the instructions provided by your doctor or pharmacist.
It is recommended to consume the product within 24 hours before your next scheduled scheduled time. You must not drink alcohol excessively while taking Ventolin Syrup. You should not drive, operate heavy machinery or do other activities that require alertness until you are ready for it. Do not drive if you have any concerns about your medication. Do not drive if you are a senior or working age person or if you are pregnant or trying to get pregnant.
Storage:Store the medication in a cool, dry place away from direct heat and moisture. It is recommended that you follow the instructions for use on the packaging carefully. The medication should be stored in its original container or container sealed.
Precautions:
You should not drink alcohol excessively while taking this medication. It is advisable to avoid alcohol while you are taking this medication, as it can increase the risk of side effects.
It is essential to inform your doctor of any medications, supplements, or herbs you are taking while on this medication. You should also inform your doctor if you are taking any other medicines, especially beta-blockers (including beta- blockers) or corticosteroids (including corticosteroids).
Consult your doctor if you are pregnant or breastfeeding.
Ventolin Syrup is a medication used to treat bronchospasm. It relieves the breathing symptoms associated with asthma, such as wheezing, coughing, chest tightness, and shortness of breath. It is not recommended to take Ventolin Syrup if you plan to become pregnant or breast feeding. It is not advisable to take Ventolin Syrup if you are allergic to Salbutamol or any other ingredients in the medication. Inform your doctor about all the medicines you are taking.
If you have any questions about this medication or its use, please consult your doctor or pharmacist.
Ventolin is commonly prescribed as an aerosol inhalant administered through an inhaler. For most individuals, two inhalations should be taken every four to six hours. This usually comes out to about two inhalations four times a day. More frequent inhalations are not recommended.
To prevent exercise-induced bronchospasms, it is recommended that you take two inhalations of Ventolin fifteen minutes before physical activity.
The exact dosage and schedule will vary depending on the patient's age, body weight, and severity of the condition. Take the medication exactly as your doctor has instructed.
Do not increase your dosage or discontinue the use of Ventolin unless ordered to do so by your doctor. If you experience any adverse reactions, contact a health care provider. Your dosage may increase or decrease depending on your doctor’s orders.
You should store your medication in a closed container at room temperature, away from extreme heat, extreme cold, moisture, and direct light, and keep it out of the reach of children.
GarglingRemove cap from seal and dark dark blue ink on one side and dark green ink on other.
SalbutamolRemove mouthpiece from ear and mouth and hold mouthpiece between cheek.
Remove earring and hold mouthpiece between cheek.
Place earring between cheek.
Remove earring and hold mouthpiece.
Alternate Name:Bristol-Myers Squibb Asthma inhalation device
Description:Oral Reliever Ventolin HFA is used for the treatment of asthma in adults and children over 4 years of age. The generic alternative is OTC.Dosage Form:Capsule
Administration Route:By mouth.Drug Class:Salbutamol HFA
Generic Available:YesDoes the job?
Yes, the job is performing!
Strength Limit:CapsulesUse:Use as Medication to Treat Asthma
Bristol-Myers Squibb Asthma
Reliever Ventolin HFA is used for the treatment of asthma in adults and children over 4 years of age. The generic alternative is Ventolin HFA
Dosage Limit:Uses:Reliever Ventolin HFA
Novel Alternative Names:Bristol-Myers Squibb Asthma, Salbutamol HFA, Reliever Ventolin HFA
Novel Symptoms:
Novel U. S. Brand Names:
Novel Rx Names:
Non-Medicinal Product Types:No
Other Products:HFA (hormonal product), Metered Dose inhaler
Additional Product Information:· Reliever Ventolin HFA (hormonal product), Metered Dose inhaler
· Salbutamol HFA (hormonal product), Metered Dose inhaler
MoreReliever Ventolin HFA is a brand name for a medication that belongs to the group of salbutamol HFA. It is used to relieve wheezing and shortness of breath caused by asthma.
Reliever Ventolin HFA is available both by prescription and over the counter in the form of a inhaler.
For more information about Ventolin HFA, talk to a health care provider about other asthma medications and asthma treatment.
Always use Ventolin HFA as directed by your healthcare provider. Inhale the inhaler, and close the mouth after using the medication to reduce the risk of breathing upsets your stomach. Take your medication exactly as directed. Ventolin HFA inhalers are only available with a valid prescription from your healthcare provider.
MEDICATION
For information about other asthma medications, talk to a healthcare provider about other asthma treatments and asthma treatment.
See also:
.
PregnancyMore about asthma inhalation devicesMore about Ventolin HFAMore about Salbutamol HFAVentolin is commonly prescribed as an aerosol inhalant administered through an inhaler. For most individuals, two inhalations should be taken every four to six hours. This usually comes out to about two inhalations four times a day. More frequent inhalations are not recommended.
To prevent exercise-induced bronchospasms, it is recommended that you take two inhalations of Ventolin fifteen minutes before physical activity.
The exact dosage and schedule will vary depending on the patient's age, body weight, and severity of the condition. Take the medication exactly as your doctor has instructed.
Do not increase your dosage or discontinue the use of Ventolin unless ordered to do so by your doctor. If you experience any adverse reactions, contact a health care provider. Your dosage may increase or decrease depending on your doctor’s orders.
You should store your medication in a closed container at room temperature, away from extreme heat, extreme cold, moisture, and direct light, and keep it out of the reach of children.
GarglingActive Ingredient:VentolinThis product is capable of causing periodic allergic responses (allergen-related) by itself.
If your doctor has prescribed you Ventolin for a higher risk of developing serious lung disease or cancer, you may be more susceptible than likely to be allergic to this medication. Talk to your doctor about the risks and benefits of this treatment.
The symptoms of allergic reactions may include:
If you develop any of these symptoms while using this treatment, stop taking Ventolin and see your doctor immediately.
Fluid buildupThis medication works by increasing the amount of oxygen within the body.
If you have a risk factors for heart disease, high blood pressure, or liver or kidney problems, or are taking other drugs for HIV or other HIV-infections, you may be more susceptible to a rare side effect of this treatment:
If you already have a history of breathing problems or serious heart problems, chest pain, irregular heartbeat, or fast or irregular heartbeat, and you are taking any other PDE5 inhibitor, consult your doctor before taking this medication.
Fluid buildup may worsen during the day or worsen at night. You should exercise caution if you have trouble sleeping at night, or if you feel dizzy.
If you have a risk factors for heart disease, high blood pressure, or liver or kidney problems, or you are taking any other drugs for HIV or other HIV-infections, you may be more susceptible than likely to be allergic to this medication.
If you already have a history of breathing problems or serious heart problems, chest pain, irregular heartbeat, or fast or irregular heartbeat, you may be more susceptible than likely to be to this treatment than if you have not previously had a history of these conditions.
Fluid buildup may mask symptoms of a serious lung problem or cancer.
You should not exercise any caution if you have trouble sleeping at night, or if you feel dizzy.